Involvement of CX3CR1 in bone cancer pain through the activation of microglia p38 MAPK pathway in the spinal cord
- PMID: 22613229
- DOI: 10.1016/j.brainres.2012.05.020
Involvement of CX3CR1 in bone cancer pain through the activation of microglia p38 MAPK pathway in the spinal cord
Abstract
Previous studies have demonstrated that fractalkine, a newly discovered chemokine, is implicated in spinal cord neuron-to-microglia activation signaling as well as mediation of neuropathic and inflammatory pain via its sole receptor CX3CR1, which is specifically expressed on microglia. However, whether it is involved in bone cancer pain (BCP) and the underlying mechanisms have not been elucidated. In this study we utilized a Sprague-Dawley rat animal model, and our findings indicated that on day 6, 12, and 18 following bone cancer pain induced by Walker 256 cell inoculation, the expression level of CX3CR1 in the spinal cord gradually increased. Intrathecal injection of a neutralizing antibody against CX3CR1 not only delayed the initiation of mechanical allodynia, but also attenuated established pain sensitization of BCP rats. Furthermore, we demonstrated that blockade of CX3CR1 suppressed the activation of microglia and the expression of p38 mitogen-activated protein kinase (MAPK) in the spinal cord in BCP rats. These results suggest a new mechanism of BCP, in which the microglia CX3CR1/p38 signaling cascade potentially plays an important role in facilitating pain processing in BCP rats.
Copyright © 2012 Elsevier B.V. All rights reserved.
Similar articles
-
Interleukin-6 induces microglial CX3CR1 expression in the spinal cord after peripheral nerve injury through the activation of p38 MAPK.Eur J Pain. 2010 Aug;14(7):682.e1-12. doi: 10.1016/j.ejpain.2009.10.017. Epub 2009 Dec 2. Eur J Pain. 2010. PMID: 19959384
-
Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine.Brain Behav Immun. 2007 Jul;21(5):642-51. doi: 10.1016/j.bbi.2006.11.003. Epub 2006 Dec 15. Brain Behav Immun. 2007. PMID: 17174525 Free PMC article.
-
Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice.J Neurochem. 2010 Aug;114(4):1143-57. doi: 10.1111/j.1471-4159.2010.06837.x. Epub 2010 May 28. J Neurochem. 2010. PMID: 20524966
-
Exercise, Spinal Microglia and Neuropathic Pain: Potential Molecular Mechanisms.Neurochem Res. 2024 Jan;49(1):29-37. doi: 10.1007/s11064-023-04025-4. Epub 2023 Sep 19. Neurochem Res. 2024. PMID: 37725293 Free PMC article. Review.
-
Biochemical and pharmacological assessment of MAP-kinase signaling along pain pathways in experimental rodent models: a potential tool for the discovery of novel antinociceptive therapeutics.Biochem Pharmacol. 2014 Feb 1;87(3):390-8. doi: 10.1016/j.bcp.2013.11.019. Epub 2013 Dec 1. Biochem Pharmacol. 2014. PMID: 24300134 Review.
Cited by
-
Monocyte chemoattractant protein-1 contributes to morphine tolerance in rats with cancer-induced bone pain.Exp Ther Med. 2017 Feb;13(2):461-466. doi: 10.3892/etm.2016.3979. Epub 2016 Dec 16. Exp Ther Med. 2017. PMID: 28352316 Free PMC article.
-
Functional neural-bone marrow pathways: implications in hypertension and cardiovascular disease.Hypertension. 2014 Jun;63(6):e129-39. doi: 10.1161/HYPERTENSIONAHA.114.02440. Epub 2014 Mar 31. Hypertension. 2014. PMID: 24688127 Free PMC article. Review. No abstract available.
-
Nuclear factor kappa B regulated monocyte chemoattractant protein-1/chemokine CC motif receptor-2 expressing in spinal cord contributes to the maintenance of cancer-induced bone pain in rats.Mol Pain. 2018 Jan-Dec;14:1744806918788681. doi: 10.1177/1744806918788681. Epub 2018 Jun 29. Mol Pain. 2018. PMID: 29956585 Free PMC article.
-
CXCL12 in astrocytes contributes to bone cancer pain through CXCR4-mediated neuronal sensitization and glial activation in rat spinal cord.J Neuroinflammation. 2014 Apr 16;11:75. doi: 10.1186/1742-2094-11-75. J Neuroinflammation. 2014. PMID: 24735601 Free PMC article.
-
The therapeutic potential of targeting chemokine signalling in the treatment of chronic pain.J Neurochem. 2017 May;141(4):520-531. doi: 10.1111/jnc.13927. Epub 2017 Feb 24. J Neurochem. 2017. PMID: 27973687 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
